AOD-9604 is a research peptide commonly studied for metabolic and fat-loss pathways. Typical research protocols involve subcutaneous administration at low microgram doses over structured cycles, with careful handling after reconstitution to maintain solution integrity.
$89.00
For laboratory research use only. Not for human or animal use or consumption. Not a drug, food, dietary supplement, or cosmetic. Not approved by the FDA for any medical use.
AOD-9604 is a modified peptide fragment derived from human growth hormone, widely researched for its potential role in metabolic regulation and fat-loss signaling pathways. It is commonly utilized in laboratory research settings focusing on lipid metabolism without significantly impacting blood glucose or growth hormone levels.
Typical Dose Range:
400–600 mcg per day, administered subcutaneously, 5 times per week.
Administration Timing:
Often administered in the morning on an empty stomach to optimize absorption in research protocols.
Cycle Length:
8–10 weeks, with an extended off-cycle of 4–8 weeks recommended between cycles.
Important Notes:
Dosage units may be adjusted slightly for practical administration purposes. Minor variations in dosage are not expected to significantly impact observed research outcomes.
Due to its hydrophobic nature, AOD-9604 may occasionally develop a gel-like consistency following reconstitution. This can occur as a result of peptide concentration, pH levels, excipient composition, or storage temperature and does not necessarily indicate degradation or loss of potency.
If gelling occurs, gently roll or invert the vial to redisperse the solution. Do not shake vigorously, as agitation may denature the peptide. Always inspect the solution for clarity and uniformity prior to use. Discontinue use if visible particulates, discoloration, or persistent cloudiness are present.
Reviews
There are no reviews yet.